Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel

Neurobiology of Disease

Volumn 43, Issue 1, 2011, Pages 163-175

  Shemesh, Or A ^a   Spira, Micha E ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alzheimer's disease; Microtubules; Paclitaxel; Tau; Tauopathy; Taxol

Indexed keywords

GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PACLITAXEL; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; APLYSIA; ARTICLE; AUTOPHAGOSOME; CELL ORGANELLE; CELL STRUCTURE; CELL SWELLING; CELL TRANSPORT; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; LYSOSOME; MICROTUBULE; NERVE DEGENERATION; NERVE FIBER; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; TAUOPATHY;

ALZHEIMER DISEASE; ANIMALS; APLYSIA; CELLS, CULTURED; HUMANS; MITOSIS; NERVE DEGENERATION; NEURONS; PACLITAXEL; PROTEIN UNFOLDING; TAU PROTEINS; TAUOPATHIES; TRANSDUCTION, GENETIC; TUBULIN MODULATORS;

EID: 79955952344     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2011.03.008     Document Type: Article

References (73)

1. Ahmad F.J., Yu W., McNally F.J., Baas P.W. An essential role for katanin in severing microtubules in the neuron. J. Cell Biol. 1999, 145:305-315.
2. Amos L.A., Lowe J. How Taxol stabilises microtubule structure. Chem. Biol. 1999, 6:R65-R69.
3. Baas P.W., Karabay A., Qiang L. Microtubules cut and run. Trends Cell Biol. 2005, 15:518-524.
4. Baas P.W., Qiang L. Neuronal microtubules: when the MAP is the roadblock. Trends Cell Biol. 2005, 15:183-187.
5. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
6. Bergstralh D.T., Ting J.P. Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat. Rev. 2006, 32:166-179.
7. Billingsley M.L., Kincaid R.L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem. J. 1997, 323(Pt 3):577-591.
8. Blagosklonny M.V., Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int. J. Cancer 1999, 83:151-156.
9. Boehmerle W., Splittgerber U., Lazarus M.B., McKenzie K.M., Johnston D.G., Austin D.J., Ehrlich B.E. Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18356-18361.
10. Boehmerle W., Zhang K., Sivula M., Heidrich F.M., Lee Y., Jordt S.E., Ehrlich B.E. Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11103-11108.
11. Bramblett G.T., Goedert M., Jakes R., Merrick S.E., Trojanowski J.Q., Lee V.M. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099.
12. Brandt R., Leger J., Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell Biol. 1995, 131:1327-1340.
13. Brunden K.R., Ballatore C., Crowe A., Smith A.B., Lee V.M., Trojanowski J.Q. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp. Neurol. 2010, 223:304-310.
14. Brunden K.R., Trojanowski J.Q., Lee V.M. Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat. Rev. Drug Discov. 2009, 8:783-793.
15. Brunden K.R., Zhang B., Carroll J., Yao Y., Potuzak J.S., Hogan A.M., Iba M., James M.J., Xie S.X., Ballatore C., et al. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy. J. Neurosci. 2010, 30:13861-13866.
16. Butler D., Bendiske J., Michaelis M.L., Karanian D.A., Bahr B.A. Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. Eur. J. Pharmacol. 2007, 562:20-27.
17. Conejero-Goldberg C., Townsend K., Davies P. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells. J. Mol. Neurosci. 2008, 35:143-150.
18. Cowan C.M., Bossing T., Page A., Shepherd D., Mudher A. Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo. Acta Neuropathol. 2010, 120:593-604.
19. Cowan C.M., Chee F., Shepherd D., Mudher A. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy. Biochem. Soc. Trans. 2010, 38:564-570.
20. De Brabander M., Geuens G., Nuydens R., Willebrords R., De Mey J. Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:5608-5612.
21. Dehmelt L., Nalbant P., Steffen W., Halpain S. A microtubule-based, dynein-dependent force induces local cell protrusions: implications for neurite initiation. Brain Cell Biol. 2006, 35:39-56.
22. Ding H., Johnson G.V. The last tangle of tau. J. Alzheimers Dis. 2008, 14:441-447.
23. Drechsel D.N., Hyman A.A., Cobb M.H., Kirschner M.W. Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol. Biol. Cell 1992, 3:1141-1154.
24. Erez H., Malkinson G., Prager-Khoutorsky M., De Zeeuw C.I., Hoogenraad C.C., Spira M.E. Formation of microtubule-based traps controls the sorting and concentration of vesicles to restricted sites of regenerating neurons after axotomy. J. Cell Biol. 2007, 176:497-507.
25. Erez H., Spira M.E. Local self-assembly mechanisms underlie the differential transformation of the proximal and distal cut axonal ends into functional and aberrant growth cones. J. Comp. Neurol. 2008, 507. spc1.
26. Evans K.J., Gomes E.R., Reisenweber S.M., Gundersen G.G., Lauring B.P. Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing. J. Cell Biol. 2005, 168:599-606.
27. Feyen F., Cachoux F., Gertsch J., Wartmann M., Altmann K.H. Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization. Acc. Chem. Res. 2008, 41:21-31.
28. Florence G.J., Gardner N.M., Paterson I. Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. Nat. Prod. Rep. 2008, 25:342-375.
29. Folwell J., Cowan C.M., Ubhi K.K., Shiabh H., Newman T.A., Shepherd D., Mudher A. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease. Exp. Neurol. 2010, 223:401-409.
30. Foss M., Wilcox B.W., Alsop G.B., Zhang D. Taxol crystals can masquerade as stabilized microtubules. PLoS ONE 2008, 3:e1476.
31. Gasparini L., Terni B., Spillantini M.G. Frontotemporal dementia with tau pathology. Neurodegener. Dis. 2007, 4:236-253.
32. Huang Y., Johnson K.R., Norris J.S., Fan W. Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells. Cancer Res. 2000, 60:4426-4432.
33. Jaworski J., Hoogenraad C.C., Akhmanova A. Microtubule plus-end tracking proteins in differentiated mammalian cells. Int. J. Biochem. Cell Biol. 2008, 40:619-637.
34. Jaworski J., Kapitein L.C., Gouveia S.M., Dortland B.R., Wulf P.S., Grigoriev I., Camera P., Spangler S.A., Di Stefano P., Demmers J., et al. Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 2009, 61:85-100.
35. Jordan M.A., Kamath K. How do microtubule-targeted drugs work? An overview. Curr. Cancer Drug Targets 2007, 7:730-742.
36. Kamber D., Erez H., Spira M.E. Local calcium-dependent mechanisms determine whether a cut axonal end assembles a retarded endbulb or competent growth cone. Exp. Neurol. 2009, 219:112-125.
37. Kar S., Fan J., Smith M.J., Goedert M., Amos L.A. Repeat motifs of tau bind to the insides of microtubules in the absence of taxol. EMBO J. 2003, 22:70-77.
38. Kidd J.F., Pilkington M.F., Schell M.J., Fogarty K.E., Skepper J.N., Taylor C.W., Thorn P. Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. J. Biol. Chem. 2002, 277:6504-6510.
39. Kim T., Chang S. Quantitative evaluation of the mode of microtubule transport in Xenopus neurons. Mol. Cells 2006, 21:76-81.
40. Kingston D.G. Tubulin-interactive natural products as anticancer agents. J. Nat. Prod. 2009, 72:507-515.
41. Kraemer B.C., Zhang B., Leverenz J.B., Thomas J.H., Trojanowski J.Q., Schellenberg G.D. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:9980-9985.
42. Lee V.M., Daughenbaugh R., Trojanowski J.Q. Microtubule stabilizing drugs for the treatment of Alzheimer's disease. Neurobiol. Aging 1994, 15(Suppl 2):S87-S89.
43. Lee V.M., Goedert M., Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 2001, 24:1121-1159.
44. Ma Y., Shakiryanova D., Vardya I., Popov S.V. Quantitative analysis of microtubule transport in growing nerve processes. Curr. Biol. 2004, 14:725-730.
45. Mandelkow E.M., Mandelkow E. Tau in Alzheimer's disease. Trends Cell Biol. 1998, 8:425-427.
46. Masurovsky E.B., Peterson E.R., Crain S.M., Horwitz S.B. Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures. Brain Res. 1981, 217:392-398.
47. McNally K.P., Buster D., McNally F.J. Katanin-mediated microtubule severing can be regulated by multiple mechanisms. Cell Motil. Cytoskeleton 2002, 53:337-349.
48. Michaelis M.L., Ansar S., Chen Y., Reiff E.R., Seyb K.I., Himes R.H., Audus K.L., Georg G.I. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents. J. Pharmacol. Exp. Ther. 2005, 312:659-668.
49. Michaelis M.L., Dobrowsky R.T., Li G. Tau neurofibrillary pathology and microtubule stability. J. Mol. Neurosci. 2002, 19:289-293.
50. Michaelis M.L., Ranciat N., Chen Y., Bechtel M., Ragan R., Hepperle M., Liu Y., Georg G. Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol). J. Neurochem. 1998, 70:1623-1627.
51. Mironov S.L., Hartelt N., Ivannikov M.V. Mitochondrial K(ATP) channels in respiratory neurons and their role in the hypoxic facilitation of rhythmic activity. Brain Res. 2005, 1033:20-27.
52. Morfini G., Pigino G., Beffert U., Busciglio J., Brady S.T. Fast axonal transport misregulation and Alzheimer's disease. Neuromolecular Med. 2002, 2:89-99.
53. Nakagawa H., Koyama K., Murata Y., Morito M., Akiyama T., Nakamura Y. EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue. Oncogene 2000, 19:210-216.
54. Nixon R.A., Yang D.S., Lee J.H. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 2008, 4:590-599.
55. Perez F., Diamantopoulos G.S., Stalder R., Kreis T.E. CLIP-170 highlights growing microtubule ends in vivo. Cell 1999, 96:517-527.
56. Qiang L., Yu W., Andreadis A., Luo M., Baas P.W. Tau protects microtubules in the axon from severing by katanin. J. Neurosci. 2006, 26:3120-3129.
57. Quarmby L. Cellular Samurai: katanin and the severing of microtubules. J. Cell Sci. 2000, 113(Pt 16):2821-2827.
58. Rodi D.J., Makowski L. Similarity between the sequences of taxol-selected peptides and the disordered loop of the anti-apoptotic protein, Bcl-2. Pac. Symp. Biocomput. 1999, 532-541.
59. Sahly I., Erez H., Khoutorsky A., Shapira E., Spira M.E. Effective expression of the green fluorescent fusion proteins in cultured Aplysia neurons. J. Neurosci. Methods 2003, 126:111-117.
60. Schacher S., Proshansky E. Neurite regeneration by Aplysia neurons in dissociated cell culture: modulation by Aplysia hemolymph and the presence of the initial axonal segment. J. Neurosci. 1983, 3:2403-2413.
61. Seitz A., Kojima H., Oiwa K., Mandelkow E.M., Song Y.H., Mandelkow E. Single-molecule investigation of the interference between kinesin, tau and MAP2c. EMBO J. 2002, 21:4896-4905.
62. Shemesh O.A., Erez H., Ginzburg I., Spira M.E. Tau-induced traffic jams reflect organelles accumulation at points of microtubule polar mismatching. Traffic 2008, 9:458-471.
63. Shemesh O.A., Spira M.E. Hallmark cellular pathology of Alzheimer's disease induced by mutant human tau expression in cultured Aplysia neurons 2010, Acta Neuropathol.
64. Shemesh O.A., Spira M.E. Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy. Acta Neuropathol. 2010, 119:235-248.
65. Spira M.E., Dormann A., Ashery U., Gabso M., Gitler D., Benbassat D., Oren R., Ziv N.E. Use of Aplysia neurons for the study of cellular alterations and the resealing of transected axons in vitro. J. Neurosci. Methods 1996, 69:91-102.
66. Spira M.E., Oren R., Dormann A., Gitler D. Critical calpain-dependent ultrastructural alterations underlie the transformation of an axonal segment into a growth cone after axotomy of cultured Aplysia neurons. J. Comp. Neurol. 2003, 457:293-312.
67. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 2002, 156:1051-1063.
68. Stepanova T., Slemmer J., Hoogenraad C.C., Lansbergen G., Dortland B., De Zeeuw C.I., Grosveld F., van Cappellen G., Akhmanova A., Galjart N. Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein). J. Neurosci. 2003, 23:2655-2664.
69. Stokin G.B., Lillo C., Falzone T.L., Brusch R.G., Rockenstein E., Mount S.L., Raman R., Davies P., Masliah E., Williams D.S., Goldstein L.S. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005, 307:1282-1288.
70. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 2001, 293:711-714.
71. Zhang B., Maiti A., Shively S., Lakhani F., McDonald-Jones G., Bruce J., Lee E.B., Xie S.X., Joyce S., Li C., et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:227-231.
72. Zhang C., Sriratana A., Minamikawa T., Nagley P. Photosensitisation properties of mitochondrially localised green fluorescent protein. Biochem. Biophys. Res. Commun. 1998, 242:390-395.
73. Zhang K., Heidrich F.M., Degray B., Boehmerle W., Ehrlich B.E. Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP(3)R. J. Mol. Cell. Cardiol. 2010, 49:829-835.